1. Home
  2. BSAC vs MRNA Comparison

BSAC vs MRNA Comparison

Compare BSAC & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banco Santander - Chile ADS

BSAC

Banco Santander - Chile ADS

HOLD

Current Price

$29.72

Market Cap

13.7B

Sector

Finance

ML Signal

HOLD

Logo Moderna Inc.

MRNA

Moderna Inc.

HOLD

Current Price

$27.57

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BSAC
MRNA
Founded
1977
2010
Country
Chile
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.7B
9.3B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
BSAC
MRNA
Price
$29.72
$27.57
Analyst Decision
Hold
Hold
Analyst Count
3
13
Target Price
$26.67
$33.91
AVG Volume (30 Days)
333.3K
9.9M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
3.34%
N/A
EPS Growth
42.15
N/A
EPS
0.01
N/A
Revenue
$2,434,135,287.00
$2,232,000,000.00
Revenue This Year
$41.31
N/A
Revenue Next Year
$5.39
$0.77
P/E Ratio
$12.84
N/A
Revenue Growth
20.98
N/A
52 Week Low
$18.19
$22.28
52 Week High
$31.16
$48.92

Technical Indicators

Market Signals
Indicator
BSAC
MRNA
Relative Strength Index (RSI) 53.37 60.85
Support Level $29.05 $23.92
Resistance Level $29.58 $26.00
Average True Range (ATR) 0.54 1.29
MACD -0.01 0.32
Stochastic Oscillator 41.32 99.82

Price Performance

Historical Comparison
BSAC
MRNA

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: